Towards Herd Humanity: Covid-19 Vaccination Reluctance In Bangladesh
2021 Decision Sciences Institute Annual Conference, Vol: 52
2021
- 117Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage117
- Downloads96
- Abstract Views21
Conference Paper Description
Researchers have considered different types of vaccines and monitored their efficacy during crisis, but few have considered the readiness of society to inoculate against COVID-19. Among mass populace areas, there remains reluctance although the endorsed vaccines have generally been shown to be highly effective. Bangladesh is aiming to move forward to actualization of an immunization rate to reach herd immunity using a diverse methodology and program to overcome vaccine reluctance. This reluctance to receive the vaccine is potentially leading to a worldwide risk of not reaching herd immunity in a timely fashion. The well-being of numerous nations is dependent on overcoming this vaccine reluctance and increasing inoculation scope. Quantitative research strategies are utilized to analyze the circumstances detailed herein. Around 90% of the respondents reported that they had no sense of urgency to receive the COVID-19 vaccine and many of them clearly clarified the reasons. A multiple regression analysis is utilized to anticipate and predict the vaccine reluctance rates. We find that an evidence-based communication and distinctive approach will be needed to effectively administer the COVID-19 vaccination.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know